322 related articles for article (PubMed ID: 29046238)
1. 1,3,5-Triazines: A promising scaffold for anticancer drugs development.
Cascioferro S; Parrino B; Spanò V; Carbone A; Montalbano A; Barraja P; Diana P; Cirrincione G
Eur J Med Chem; 2017 Dec; 142():523-549. PubMed ID: 29046238
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and antitumor activities of 1,2,3-triazines and their benzo- and heterofused derivatives.
Cascioferro S; Parrino B; Spanò V; Carbone A; Montalbano A; Barraja P; Diana P; Cirrincione G
Eur J Med Chem; 2017 Dec; 142():74-86. PubMed ID: 28615111
[TBL] [Abstract][Full Text] [Related]
3. An overview on the recent developments of 1,2,4-triazine derivatives as anticancer compounds.
Cascioferro S; Parrino B; Spanò V; Carbone A; Montalbano A; Barraja P; Diana P; Cirrincione G
Eur J Med Chem; 2017 Dec; 142():328-375. PubMed ID: 28851503
[TBL] [Abstract][Full Text] [Related]
4. Triazine as a promising scaffold for its versatile biological behavior.
Singla P; Luxami V; Paul K
Eur J Med Chem; 2015 Sep; 102():39-57. PubMed ID: 26241876
[TBL] [Abstract][Full Text] [Related]
5. Uses of cyclohexane-1,3-dione for the synthesis of 1,2,4-triazine derivatives as anti-proliferative agents and tyrosine kinases inhibitors.
Megally Abdo NY; Milad Mohareb R; Halim PA
Bioorg Chem; 2020 Apr; 97():103667. PubMed ID: 32087416
[TBL] [Abstract][Full Text] [Related]
6. Solid-phase synthesis and antitumor evaluation of 2,4-diamino-6-aryl-1,3,5-triazines.
Hu Z; Ma T; Chen Z; Ye Z; Zhang G; Lou Y; Yu Y
J Comb Chem; 2009 Mar; 11(2):267-73. PubMed ID: 19125569
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, structure and anticancer activity of novel alkenyl-1,3,5-triazine derivatives.
Saczewski F; Bułakowska A
Eur J Med Chem; 2006 May; 41(5):611-5. PubMed ID: 16540207
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, Structure and Antiproliferative Activity of New pyrazolo[4,3- e]triazolo[4,5-b][1,2,4]triazine Derivatives.
Mojzych M; Tarasiuk P; Karczmarzyk Z; Juszczak M; Rzeski W; Fruzinski A; Wozny A
Med Chem; 2018; 14(1):53-59. PubMed ID: 29065838
[TBL] [Abstract][Full Text] [Related]
9. 1,3,5-Triazine-azole Hybrids and their Anticancer Activity.
Guo H; Diao QP
Curr Top Med Chem; 2020; 20(16):1481-1492. PubMed ID: 32156236
[TBL] [Abstract][Full Text] [Related]
10. Antitumor Activity of s-Triazine Derivatives: A Systematic Review.
Dai Q; Sun Q; Ouyang X; Liu J; Jin L; Liu A; He B; Fan T; Jiang Y
Molecules; 2023 May; 28(11):. PubMed ID: 37298753
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of heterobicyclic nitrogen systems bearing the 1,2,4-triazine moiety as anti-HIV and anticancer drugs: Part I.
Abdel-Rahman RM; Morsy JM; Hanafy F; Amene HA
Pharmazie; 1999 May; 54(5):347-51. PubMed ID: 10368828
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of triterpenoid triazine derivatives from allobetulone and betulonic acid with biological activities.
Dinh Ngoc T; Moons N; Kim Y; De Borggraeve W; Mashentseva A; Andrei G; Snoeck R; Balzarini J; Dehaen W
Bioorg Med Chem; 2014 Jul; 22(13):3292-300. PubMed ID: 24844757
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and in vitro anticancer evaluation of some 4,6-diamino-1,3,5-triazine-2-carbohydrazides as Rad6 ubiquitin conjugating enzyme inhibitors.
Kothayer H; Spencer SM; Tripathi K; Westwell AD; Palle K
Bioorg Med Chem Lett; 2016 Apr; 26(8):2030-4. PubMed ID: 26965855
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, structural characterization and antitumor activity of novel 2,4-diamino-1,3,5-triazine derivatives.
Brzozowski Z; Saczewski F; Gdaniec M
Eur J Med Chem; 2000 Dec; 35(12):1053-64. PubMed ID: 11248404
[TBL] [Abstract][Full Text] [Related]
15. Structure-based design and synthesis of novel macrocyclic pyrazolo[1,5-a] [1,3,5]triazine compounds as potent inhibitors of protein kinase CK2 and their anticancer activities.
Nie Z; Perretta C; Erickson P; Margosiak S; Lu J; Averill A; Almassy R; Chu S
Bioorg Med Chem Lett; 2008 Jan; 18(2):619-23. PubMed ID: 18055206
[TBL] [Abstract][Full Text] [Related]
16. o-Carboranylalkoxy-1,3,5-Triazine Derivatives: Synthesis, Characterization, X-ray Structural Studies, and Biological Activity.
Jin GF; Ban HS; Nakamura H; Lee JD
Molecules; 2018 Aug; 23(9):. PubMed ID: 30200261
[TBL] [Abstract][Full Text] [Related]
17. 1,2,3-Triazine scaffold as a potent biologically active moiety: a mini review.
Kumar R; Singh AD; Singh J; Singh H; Roy RK; Chaudhary A
Mini Rev Med Chem; 2014 Jan; 14(1):72-83. PubMed ID: 24387709
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, hypoxia-selective cytotoxicity of new 3-amino-1,2,4-benzotriazine-1,4-dioxide derivatives.
Xia Q; Zhang L; Zhang J; Sheng R; Yang B; He Q; Hu Y
Eur J Med Chem; 2011 Mar; 46(3):919-26. PubMed ID: 21281992
[TBL] [Abstract][Full Text] [Related]
19. Chemistry of uncondensed 1,2,4-triazines, Part IV. Synthesis and chemistry of bioactive 3-amino-1,2,4-triazines and related compounds--an overview.
Abdel-Rahman RM
Pharmazie; 2001 Apr; 56(4):275-86. PubMed ID: 11338663
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological evaluation of novel 6-hydrazinyl-2,4-bismorpholino pyrimidine and 1,3,5-triazine derivatives as potential antitumor agents.
Zhu W; Liu Y; Zhao Y; Wang H; Tan L; Fan W; Gong P
Arch Pharm (Weinheim); 2012 Oct; 345(10):812-21. PubMed ID: 22707438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
